As of Jan 13
| -0.79 / -0.74%|
The 6 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 139.50, with a high estimate of 160.00 and a low estimate of 105.00. The median estimate represents a +32.08% increase from the last price of 105.62.
The current consensus among 5 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.